Table 3.
Samples | Sample size | Reliable improvementa | Recoveryb | Reliable improvement or recoveryc | Reliable improvement and recoveryd | Clinically meaningful improvemente |
---|---|---|---|---|---|---|
Outcome: PTSD symptoms (PCL-5) | ||||||
Entire Sample | 199 | 164 (82.41) | – | 165 (82.91) | – | 129 (64.82) |
Baseline PCL-5 ≥ 31 | 112 | 101 (90.18) | 80 (71.43) | 102 (91.07) | 79 (70.54) | 88 (78.57) |
Outcome: depression symptoms (PHQ-9) | ||||||
Baseline PHQ-9 ≥ 10 | 74 | 37 (50.00) | 45 (60.81) | 51 (68.92) | 31 (41.89) | – |
PHQ-9 patient health questionnaire-9, PCL-5 PTSD checklist for DSM-5.
aReliable improvement: ≥ 5-point decrease on the final PCL-5; or ≥ 6-point decrease on the final PHQ-9.
bRecovery: Final PCL-5 < 31 among those with baseline PCL-5 ≥ 31; or final PHQ-9 < 10.
cReliable improvement or recovery: ≥ 5-point decrease on the final PCL-5 or final PCL-5 < 31 among those with baseline PCL-5 ≥ 31; or ≥ 6-point decrease on the final PHQ-9 or final PHQ-9 < 10.
dReliable improvement and recovery: ≥ 5-point decrease on the final PCL-5 and final PCL-5 < 31 among those with baseline PCL-5 ≥ 31; or ≥ 6-point decrease on the final PHQ-9 and final PHQ-9 < 10.
eClinically meaningful improvement: ≥ 10-point decrease on the final PCL-5.